India to Burkina Faso: Sulfamethoxazole Export Trade Route

The India to Burkina Faso Sulfamethoxazole corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $682.2K USD. The route is dominated by FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 85% of all export value, reflecting the consolidated nature of India's sulfamethoxazole manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $85.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with sulfamethoxazole's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 33.6%, placing it at rank #15 among India's top sulfamethoxazole export destinations globally.

On the import side, key buyers of Indian sulfamethoxazole in Burkina Faso include CAMEG, CAMEG , BURKINA MEDICAL FACILITY S.A.(BMF). CAMEG is the single largest importer with 6 shipments valued at $621.3K USD.

India's sulfamethoxazole exports to Burkina Faso are driven primarily by a handful of large-scale manufacturers. FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Burkina Faso benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED, FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED , FOURRTS I LABORATORIES PVT LTD — together account for 100% of total trade value on this route. The average shipment value of $85.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as cotrimoxazole tablet bp 480mg (sulfamethoxazole 400mg + trimethoprim 80mg ) ( qty - 14437 x 100 x 10s ) and cotrimoxazole tablet bp 480mg (sulfamethoxazole 400mg + trimethoprim 80mg) (qty- 7874 x 100 x 10s)nos, suggesting that buyers in Burkina Faso tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CAMEG is the largest importer with 6 shipments worth $621.3K USD — representing 91% of all sulfamethoxazole imports from India on this route.